Monica Bocchia

8.5k total citations
179 papers, 2.9k citations indexed

About

Monica Bocchia is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Monica Bocchia has authored 179 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Hematology, 80 papers in Genetics and 63 papers in Pathology and Forensic Medicine. Recurrent topics in Monica Bocchia's work include Chronic Lymphocytic Leukemia Research (69 papers), Lymphoma Diagnosis and Treatment (61 papers) and Chronic Myeloid Leukemia Treatments (38 papers). Monica Bocchia is often cited by papers focused on Chronic Lymphocytic Leukemia Research (69 papers), Lymphoma Diagnosis and Treatment (61 papers) and Chronic Myeloid Leukemia Treatments (38 papers). Monica Bocchia collaborates with scholars based in Italy, United States and United Kingdom. Monica Bocchia's co-authors include Alessandro Gozzetti, Donatella Raspadori, Tatyana Korontsvit, DA Scheinberg, Alessandro Sette, Francesco Lauria, Pier Luigi Zinzani, Francesco Forconi, Emanuele Cencini and Anna Sicuranza and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Monica Bocchia

172 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Monica Bocchia Italy	28	1.3k	1.1k	1.0k	964	850	179	2.9k
Alessandro Gozzetti Italy	28	1.7k 1.3×	928 0.9×	1.0k 1.0×	512 0.5×	619 0.7×	147	2.8k
Paula Marlton Australia	27	1.2k 1.0×	789 0.7×	988 1.0×	803 0.8×	1.0k 1.2×	137	3.1k
Preetesh Jain United States	32	1.4k 1.1×	2.2k 2.1×	1.0k 1.0×	846 0.9×	1.5k 1.8×	181	3.7k
Thomas J. Nevill Canada	25	1.8k 1.4×	632 0.6×	761 0.8×	445 0.5×	422 0.5×	99	2.5k
E Montserrat Spain	30	769 0.6×	1.4k 1.3×	1.0k 1.0×	820 0.9×	1.8k 2.1×	97	3.0k
Scott Ely United States	28	872 0.7×	737 0.7×	1.6k 1.6×	674 0.7×	1.1k 1.3×	89	3.4k
Stephen Opat Australia	25	570 0.4×	1.4k 1.3×	980 1.0×	562 0.6×	1.7k 2.0×	158	2.7k
Françoise Rigal‐Huguet France	25	1.3k 1.0×	837 0.8×	869 0.9×	283 0.3×	1.0k 1.2×	66	2.7k
Mathias Witzens‐Harig Germany	30	665 0.5×	738 0.7×	1.3k 1.3×	895 0.9×	1.1k 1.3×	136	2.8k
Stefan Faderl United States	26	2.0k 1.5×	1.7k 1.7×	548 0.5×	743 0.8×	1.0k 1.2×	115	3.6k

Countries citing papers authored by Monica Bocchia

Since Specialization

Citations

This map shows the geographic impact of Monica Bocchia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Bocchia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Bocchia more than expected).

Fields of papers citing papers by Monica Bocchia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Bocchia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Bocchia. The network helps show where Monica Bocchia may publish in the future.

Co-authorship network of co-authors of Monica Bocchia

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Bocchia. A scholar is included among the top collaborators of Monica Bocchia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Bocchia. Monica Bocchia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ciabattini, Annalisa, Fabio Fiorino, G Pastore, et al.. (2025). Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses. EBioMedicine. 113. 105577–105577. 2 indexed citations

Rondoni, Michela, Giovanni Marconi, Annalisa Nicoletti, et al.. (2025). Low WT1 Expression Identifies a Subset of Acute Myeloid Leukemia with a Distinct Genotype. Cancers. 17(7). 1213–1213.

Cencini, Emanuele, Anna Sicuranza, Alberto Fabbri, et al.. (2023). The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study. Leukemia & lymphoma. 64(10). 1634–1642. 3 indexed citations

Cencini, Emanuele, et al.. (2023). Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications. Current Oncology. 30(7). 6111–6133. 17 indexed citations

Baratè, Claudia, Alessandro Sanna, E. Benedetti, et al.. (2023). Real-life diagnostic and therapeutic approach to CLL: a 2022 update from an expert panel in Tuscany. Clinical and Experimental Medicine. 23(8). 4251–4264. 1 indexed citations

Rita, Anthea Di, et al.. (2022). Assessing gene function in human B cells: CRISPR/Cas9‐based gene editing and mRNA‐based gene expression in healthy and tumor cells. European Journal of Immunology. 52(8). 1362–1365. 3 indexed citations

Raspadori, Donatella, et al.. (2022). “Friends and foes” of multiple myeloma measurable/minimal residual disease evaluation by next generation flow. Frontiers in Oncology. 12. 1057713–1057713.

Fiorino, Fabio, Annalisa Ciabattini, Anna Sicuranza, et al.. (2022). The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients. Frontiers in Immunology. 13. 1017863–1017863. 15 indexed citations

Cencini, Emanuele, Benedetta Puccini, Federico Simonetti, et al.. (2022). Pixantrone in patients with relapsed/refractory diffuse large B‐cell lymphoma: A real‐life, retrospective, multicenter trial on behalf of the “RTL” (Regional Tuscan Lymphoma network). European Journal Of Haematology. 108(5). 383–390. 1 indexed citations

10.

Roberto, Giuseppe, Claudia Bartolini, Alessandro Barchielli, et al.. (2020). Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data. PLoS ONE. 15(3). e0229973–e0229973. 5 indexed citations

11.

Cattaneo, Francesca, Emanuele Cencini, Alessandro Gozzetti, et al.. (2017). Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia. Blood. 130(18). 2006–2017. 20 indexed citations

12.

Bocchia, Monica, Sara Galimberti, Antonella Gozzini, et al.. (2014). ATHEROTHROMBOTIC RISK ASSESSMENT DURING TYROSINE KINASE INHIBITORS TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS: NEW INSIGHT?. Haematologica. 99. 533–534. 1 indexed citations

13.

Filì, Carla, Michele Malagola, Matilde Y. Follo, et al.. (2013). Prospective Phase II Study on 5-Days Azacitidine for Treatment of Symptomatic and/or Erythropoietin Unresponsive Patients with Low/INT-1–Risk Myelodysplastic Syndromes. Clinical Cancer Research. 19(12). 3297–3308. 56 indexed citations

14.

Puccetti, Luca, Sara Galimberti, Antonella Gozzini, et al.. (2013). Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status?. Blood. 122(21). 1482–1482. 6 indexed citations

15.

Defina, Marzia, Alessandro Gozzetti, Elisabetta Abruzzese, et al.. (2012). Evaluation of residual CD34⁺Ph⁺ progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first‐line nilotinib therapy. Cancer. 118(21). 5265–5269. 10 indexed citations

16.

Gozzetti, Alessandro, Alberto Fabbri, Stefania Oliva, et al.. (2010). Weekly Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone Is a Safe and Effective Therapy for Elderly Patients With Relapsed/Refractory Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 10(1). 68–72. 11 indexed citations

17.

Bocchia, Monica, et al.. (2009). BCR-ABL DERIVED PEPTIDE VACCINES FOR CHRONIC MYELOID LEUKAEMIA. 1(1). 11–14. 1 indexed citations

18.

Zaja, Francesco, Marta Lisa Battista, Marco Montagna, et al.. (2008). Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura. Haematologica. 93(6). 930–933. 78 indexed citations

19.

Mazza, Patrizio, Monica Bocchia, Fabio Tumietto, et al.. (1992). Recombinant interleukin‐2 (rIL‐2) in acquired immune deficiency syndrome (AIDS): Preliminary report in patients with lymphoma associated with HIV infection. European Journal Of Haematology. 49(1). 1–6. 12 indexed citations

20.

Zinzani, Pier Luigi, Patrizio Mazza, Filíppo Gherlinzoni, et al.. (1990). Ceop Regimen in the Treatment of Advanced Low-Grade Non-Hodgkin's Lymphomas: Preliminary Report. Tumori Journal. 76(6). 533–536. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact